GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ascendis Pharma A/S (NAS:ASND) » Definitions » 6-1 Month Momentum %

Ascendis Pharma A/S (Ascendis Pharma A/S) 6-1 Month Momentum % : 57.95% (As of May. 06, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Ascendis Pharma A/S 6-1 Month Momentum %?

6-1 Month Momentum % is the total return of the stock from 6-month ago to 1-month ago. As of today (2024-05-06), Ascendis Pharma A/S's 6-1 Month Momentum % is 57.95%.

The industry rank for Ascendis Pharma A/S's 6-1 Month Momentum % or its related term are showing as below:

ASND's 6-1 Month Momentum % is ranked better than
82% of 1517 companies
in the Biotechnology industry
Industry Median: 0.17 vs ASND: 57.95

Competitive Comparison of Ascendis Pharma A/S's 6-1 Month Momentum %

For the Biotechnology subindustry, Ascendis Pharma A/S's 6-1 Month Momentum %, along with its competitors' market caps and 6-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ascendis Pharma A/S's 6-1 Month Momentum % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Ascendis Pharma A/S's 6-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where Ascendis Pharma A/S's 6-1 Month Momentum % falls into.



Ascendis Pharma A/S  (NAS:ASND) 6-1 Month Momentum % Calculation

6-1 Month Momentum % is calculated as following:

6-1 Month Momentum %=( Price 1-month ago / Price 6-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ascendis Pharma A/S  (NAS:ASND) 6-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 6-1 Month Momentum % measures the total return to a stock over the past six months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.


Ascendis Pharma A/S 6-1 Month Momentum % Related Terms

Thank you for viewing the detailed overview of Ascendis Pharma A/S's 6-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.


Ascendis Pharma A/S (Ascendis Pharma A/S) Business Description

Traded in Other Exchanges
Address
Tuborg Boulevard 12, Hellerup, DNK, DK-2900
Ascendis Pharma A/S is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates in North America, China, and Europe and derives the majority of its revenue from North America.

Ascendis Pharma A/S (Ascendis Pharma A/S) Headlines

From GuruFocus

Ascendis Pharma Reports First Quarter 2023 Financial Results

By sperokesalga sperokesalga 04-27-2023